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1. Introduction  
Heart transplantation is the ultimate therapy for patients in the end stage of heart failure in 
order to either restore or promote patients a better functional performance (Bocchi, 2001; 
Guimarães, 1999).  
The first heart transplant in the world was performed in 1967 and the procedure has been 
even more present in this area since then (Kaye, 1993). Several clinical efforts and advances 
were seen in the last decade in this field, with the incorporation of new surgical techniques, 
new immunosuppressive drugs, new diagnostic methods and approaches in the early and 
late postoperative. All advances were able to contribute to greater functional status and less 
impairment or co-morbidities. 
Many different centers around in the world perform heart transplantation and, thus, are 
able to contribute to favorable results in terms of survival and quality of life on heart 
transplant recipients (Bocchi, 1999). 
The practice of regular physical activity has been recommended for rehabilitation after cardiac 
transplantation in order to reduce and control co-morbidities (such as hypertension, diabetes, 
vascular disorders, mainly developed due to continuous use of immunosuppressive drugs), as 
well as to restore physical capacity and daily activities (Guimarães, 1999).  
Nevertheless, crucial attention is needed when prescribing a physical activity program 
heading for heart transplant recipients, because they remain with some impairment 
previously to the surgery, and gain some other disabilities due to the transplantation 
procedure itself and due to the use of required drugs to control organ rejection. 
2. Prevalence  
Heart failure (HF) is the final common pathway of most diseases which affect the heart, and it 
is performed in these patients because of the severity and urgency of their disease (Reemtsma, 
1985). Thus, heart transplant, or a cardiac transplantation, is a surgical transplant procedure 
performed on these patients and it is recognized as the gold standard therapy for patients 
facing the end stage of heart failure because there is an increased worsening imbalance 
between the demand for transplants and the supply of the organs in HF (Haywood, 1996). 
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The surgical procedure takes a working heart from a recently deceased organ donor (an 
allograft) and implants it into the patient (called recipient). The patient's own heart may 
either be removed (orthotopic transplant) or, less commonly, left in to support the donor 
heart (heterotopic transplant);  
The cardiac transplantation contributes to a low operative mortality but an undesirable high 
postoperative mortality. This elucidates the fact that heart failure and the surgery represent 
some important current clinical challenges in healthcare and an epidemic in progress 
(Guimarães, 2004).  
Whenever there is a careful selection for choosing the donor and recipient, there is also a 
significant increase in survival, exercise capacity, on return to work and quality of life of this 
group of patients (Banner, 1989). 
From the early 80’s, almost 10% of people died on the waiting list for cardiac 
transplantation, mostly due to sudden cardiac deaths, and the average length of time 
patients wait before undergoing transplantation is increasing each decade (Haywood, 1996) 
maybe because of the increase number of patients suffering from HF and the improvement 
of its palliative treatment (Guimarães, 2004). 
Heart transplantation has evolved and long term survival is expected for most heart 
transplant recipient because of the improvements in organ preservation, surgery and 
immunosuppressive drug management, and physical rehabilitation.  
3. Pathophysiology  
In general, heart transplant surgery has become an effective therapeutic option in the 
management of end stage heart disease because it is able to restore physical function 
because the new heart doesn’t have the limitations the old heart had.  
There is an association of better left ventricular function one year after cardiac transplant 
operation with donor-related factors (donor age and sex, ischemia time), and with recipient-
related factors (recipient age and sex, frequency of acute rejection), type of 
immunosuppressant drug, and frequency of hypertension (Reid, 1988). 
However, the procedure itself promotes complete organ denervation by the postganglionic 
neural axons section. During heart transplant surgery, the atria of both, the giver and the 
receiver are sutured together (el-Gamel, 1998). The original sinoatrial node remains 
innervated, the vagus nerve is severed during the operation, but the electrical impulses 
generated by it cannot cross over the suture line.  
Because the sinoatrial node of the transplanted heart, which determines heart rate (HR) is 
totally denervated, this neural section may be responsible for either a delay or an 
unsatisfactory autonomic response (Guimarães, 1999), which will depend mostly on 
circulating catecholamines to stimulate the heart (Kaye, 1977) unless nerve regrowth 
occurs. 
Therefore, the absence of afferent neural control of heart rate leaves the heart under the 
influence of hormones in addition to internal control. The lack of neural signals to the 
sinoatrial node is indicated by the reduced maximal HR, heart rate variability, as well as 
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changes in the HR response during exercise (Di Rienzo, 2001) and during change of posture 
(Doering, 1996).  
The surgery in these patients promotes inefficient control of heart rate (Kaye, 1977) usually 
with a high resting HR and a small increase in HR in the first minutes of exercise. Perhaps 
maximal HR is reached in the recovery period of exercise, and not at peak exercise, taking 
longer to return to baseline (Guimarães, 1999), as previous shown in Fig. 1. 
However, the vasomotor control (neural and hormonal) is not affected by surgery. The 
changes in this system may appear due to adaptive mechanisms to drug therapy (Toledo, 
2002). 
Initially it was thought that the denervation was permanent, and there was only the 
dependence on circulating catecholamines to achieve maximal heart inotropic and 
chronotropic stimulation (Kaye, 1977). As time passed by and recent studies have been 
performed, it has been shown that there is a reinnervation process over time after surgery 
(Fuentes, 2010), because significant higher VO2, AT (anaerobic threshold), VE 
(Schwaiblmair, 1999), myocardial function and coronary artery tone are shown after this 
surgery (Burke, 1995). reinnervation happens in an heterogeneous pattern (Wilson, 1993). 
It is known that time after transplantation is recognized as a significant factor correlated to 
partial autonomic reinnervation among these recipients (Schwaiblmair, 1999). In the 
majority of recipients with more than one year after cardiac transplantation, cardiac 
norepinephrine reapers. This support the presence of late heterogeneous sympathetic 
reinnervation (Wilson, 1993). 
Data from Heart Failure Clinics of Heart Institute compare the O2 consumption increase to 
the heart rate increase during exercise. It shows that a cardiac transplant recipient at short-
term transplantation have the increase of VO2 during cardiopulmonary exercise test not 
matched to the increase in HR (Figure 1). The same patient at long-term transplantation 
showed a closer relationship to this increase (Figure 2), so this might corroborate the idea of 
partial reinnervation described over time. 
 
 
Fig. 1. Response in recent (5 month) post transplant recipients. HR in red, VO2 in green. 
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Fig. 2. Response in late (9 year) post transplant recipients. HR in red, VO2 in green. 
Thus, heart rate control acts different from healthy subjects. It becomes more elevated at rest; 
nevertheless, during exercise, there is gradual delay of its increase from the exercise start to the 
peak HR. As a result, by the time heart transplant recipients reach their peak HR, it is, indeed, 
lower than peak HR in healthy subjects. Then, HR decreases in a slow way during the 
recovery period (Guimarães, 1999). This described finding in exercise could be identified in 
one of the patient referred to Heart Failure Clinics of Heart Institute, in Brazil (Figure. 3). 
 
Fig. 3. Heart rate(HR) representation in a sedentary healthy subject (in red) and in a 
sedentary heart transplantation recipient (in blue).  
Comparing the same data from heart transplant recipients and heart failure patients from 
Heart Failure Clinics of Heart Institute, both, resting HR and peak HR, after surgery 
becomes significantly higher compared to the same data from healthy subjects, although 
there is no change in their HR reserve (Figure 4). 
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Fig. 4. Resting heart rate, peak heart rate and heart rate reserve in heart failure patients and 
heart transplant recipients ; HR — heart rate. 
Peak heart rate (percentage of the maximum predicted for age) is significant higher in heart 
transplant recipients than in heart failure patients (Carvalho, 2009a) because the heart 
remains partially denervated, as it is shown in Figure 5. Thus, the general use of maximum 
HR adjusted for age recommended by the Task Force, 2006, known as 220 – age, cannot be 
applied to transplant recipients in order to identify their maximum effort and to prescribe 
exercise (Casadei, 1992; Guimarães, 2010). 
Indeed, no patient reached the maximum heart rate predicted for their age during a 
treadmill cardiopulmonary exercise test. A heart rate increase in heart transplant patients 
during cardiopulmonary exercise test comes around 80% of the maximum age-adjusted 
value (Carvalho, 2009a).   
Masked mechanisms responsible for the increase of cardiac output in these patients have 
close correlation to reaching their physical capacity (Casadei, 1992). In fact, heart transplant 
recipient’s norepinephrine plasma level is lower, at rest, than either healthy or heart failure 
subjects. But it becomes twice higher than healthy subjects do, after the 6-minute walking 
test (Guimarães, 2010).  
Increases in heart rate and stroke volume at exercise are first linked to the augmented 
venous return, and later to the increased plasmatic noradrenaline level. Hence, reduced 
cardiac output response to exercise results in early anaerobic metabolism, acidosis, 
hyperventilation and diminished physical capacity. 
Peak oxygen consumption is reduced in transplant recipients compared to healthy subjects, 
which may be related to the existence of remaining systolic and diastolic dysfunction (Patel, 
2003), muscular atrophy and hormonal abnormalities due to heart failure persistence after 
transplantation (Gryglewski, 2001), in addition to the use immunosuppressive drugs that 
reduce exercise capacity, and sympathetic stimulation (Banner, 1989).  
A strong relationship was found between percentage of heart rate reserve (%HRR) and 
percentage of oxygen consumption reserve (%VO2R) in heart transplant during 
cardiopulmonary exercise test, as it follows in Figure 6 (r=0.95, p<0.0001). The %HRR–
%VO2R linear regression between 0 intercept and 1 intercept between the slope of each  
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Fig. 5. Mean peak heart rate (percentage of the maximum heart rate predicted for age) in 
heart failure patients and in heart transplantation recipients. Data is presented as the mean ± 
95% confidence interval.  
patient showed a slope of −0.23, which means that it is far from the perfection expressed by 
a slope of 1. Perhaps different terms of heart transplantation and, consequently, different 
reinnervation status patients could have influenced the imperfect reliability of the %HRR 
versus %VO2R (Carvalho, 2009b). 
 
Fig. 6. Percentage of heart rate reserve (%HRR) and percentage of oxygen consumption 
reserve (%VO2R) 
A close relationship was also found between %peak heart rate versus %peakVO2 (r=0.91, 
p<0.0001) and absolute heart rate versus absolute VO2 (r=0.67, p<0.0001). They are 
expressed in both, Figure 7 and Figure 8, data extracted from Heart Failure Clinics of Heart 
Institute (Carvalho, 2009b). 
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Fig. 7. Heart rate (HR) and peak oxygen consumption (VO2)  
 
 
Fig. 8. The plot represents stage by stage regression of the cardiopulmonary exercise test. 
The grey is the identity line and the black line is regression line. Linear regression between 0 
intercept and 1 intercept to percentage of heart rate reserve (%HRR) and percentage of 
oxygen consumption reserve (%VO2R) of each patient. 
The increased of muscle work and/or activation of the neurohormonal system, in order to 
maintain, reduced or increase blood pressure and heart rate as an answer to exercise is 
mainly responsible for the decrease in physical capacity among heart transplant recipients. 
This decrease in physical capacity after transplantation leads to insufficient production of 
nitric oxide (Fischer, 2005) and prostacyclin (Guimaraes, 2007), as well as hyperemia 
dysfunctional, and activation of other compensatory mechanisms. This occurs mainly when 
there is increased muscle work and/or activation of the neurohormonal system, in order to 
perform maintenance, reduced or increased blood pressure and heart rate in response to 
exercise intensity (Poston, 1999; Carvalho, 2009c). 
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It has also been reported that physical work capacity in heart transplant recipients decrease 
typically 40% of age-predicted normal levels (Goodman, 2007). 
 Finally, the reduction in arterial compliance observed after transplant may be due to 
changes on endothelial dysfunction or vascular mechanisms. Moreover, greater sympathetic 
nerve activity can lead to increased smooth muscle tone of arteries and, consequently, 
increase of the vessels stiffness (Taylor, 2003; Degertekin, 2002).  
4. Exercise program in heart transplanted patients 
Regular physical activity has played important role in the improvement of quality, as 
demonstrated in studies because regular physical activity may revert or diminish the 
physiological alterations in transplanted patients (Fig.9 ) (Guimarães, 2004). 
 
Fig. 9. Association between physical capacity and heart transplantation and the potential 
role of physical training on the systemic improvement, on the physiopathological effect, on 
quality of life and on functional capacity 
5. Exercise in ICU (intensive care unit) 
Even in the earliest days after surgery, the physical therapist will begin to work. Exercise in 
this scenario is important for several reasons. It aims to restore pulmonary capacity once a 
median sternotomy procedure is performed and can cause diaphragm reflex inhibition, pain 
whenever breathing. It also looks for reducing chances of getting lung infections, 
thromboembolism, bedsores and decrements in peak oxygen consumption (VO2peak) and 
related cardiovascular parameters (which may regress approximately 26% within the first 1 
to 3 weeks of sustained bed rest) (Braith, 2000) . 
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Types of exercise include respiratory ones, either with or without equipments, exercises in 
bed, changing positions in bed, sitting, standing and walking. 
 Recipients remain in hospital post-transplant depending on their general improvement and 
lack of complication. Different from pretransplantation hospitalization, which may be 
prolonged for inotropic support or a ventricular assist device, they leave hospitals soon after 
surgery because of the risk of infection in a hospital (usually after 2 weeks if there aren’t any 
complications) and are discharged from the unit to a rehabilitation program.  
6. Exercise prescription 
After heart transplantation patients show physical deconditioning, muscular atrophy, 
weakness and lower maximal aerobic capacity so regular aerobic/strength training have 
been studied in both post-heart transplant recipients adults (Keteyian, 1991) and children 
(Patel, 2008) to study whether it would improve exercise performance. Most programs 
currently treating orthotopic transplant patients usually provide 6-12 week of exercise 
training.  
In general overview, exercise program improves maximal O2 consumption and, by 
improving peak heart rate and also improves O2 delivery in adults after a 10-week exercise 
program (Keteyian, 1991). 
Benefits have also been found in children. After an exercise intervention consisted of aerobic 
exercise (either running or bicycling for 30 minutes three days/week), plus strength training 
was performed with elastic bands to specifically exercise biceps and triceps groups for 15-20 
min/session was responsible for pediatric heart recipients improvement in their endurance 
time, peak oxygen consumption and strength.  
Studies on aerobic training after cardiac transplantation have distinct characteristics of 
intensity, type, duration and frequency, so that the evaluation of the results on the effects on 
the cardiovascular system should be interpreted carefully. Moreover, the intensity of the 
exercise may enable or help to depress the immune system by hormonal, metabolic and 
mechanical mechanisms; however, there are no studies about the effect of intensity on the 
immune response in this population. (Guimarães, 1999). 
Knowing the exercise stress tests is necessary information in order to develop a correct 
exercise prescription. Naughton protocol is more recommended for these patients. Among 
the parameters, heart rate reflects the cardiac stress, and the rest and maximum, or the 
metabolic thresholds are used to prescribe the range of exercise intensity and monitor 
physical training (initially 70% heart rate reserve). (Carvalho, 2009a; Braith, 2000). 
Blood pressure during exercise reflects a combination of increased cardiac output and 
reduced peripheral resistance, thus it should also be considered when prescribing exercise 
and monitoring it. These hemodynamic variables must be observed during the rehabilitation 
program for either progression or discontinuation, if necessary.  
7. Physical exercise after hospital discharge 
Nine months after the surgery procedure, partial reinnervation shows up, but it, yet, 
promotes inefficient control of heart rate (Bernardini, 1998). This reinnervation can be 
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partially restored over the years. Although heart rate increases after an exercise program 
(Schwaiblmair, 1999), it remains attenuated, thus, not worth to precise monitor 
cardiovascular and aerobic exercise prescription. Around 80% of the maximum age-adjusted 
value could be considered an effort near the maximum, so, it may be a parameter for 
prescribing exercise (Carvalho, 2009a). 
Another good method to prescribe aerobic exercise training in heart transplant recipients 
without a cardiopulmonary exercise test with gas analysis is by the ratings of perceived 
exertion (Carvalho, 2009b). In order to achieve this purpose subjects are encouraged to do 
exercise between a relatively easy rhythm and a slightly tiring one, between 11 and 13 on the 
Borg Scale as seen in Table 1. (Guimarães, 2008).  
 
Borg Scale Self-subject fatigue association 
6  
7 Very easy 
8  
9 Easy 
10  
11 Relatively easy 
12  
13 Slightly tiring 
14  
15 Tiring 
16  
17 Very tiring 
18  
19 Exhaustive  
20  
Table 1. Borg Scale of subject fatigue. 
Comparing heart transplant recipients from our lab at Heart Failure Clinics of Heart 
Institute before and after an exercise program, a more efficient parasympathetic response 
can be identified (compare the blue line on Figure 3 to the one in Figure 10). In sedentary 
people after transplantation exercise recovery is significantly slower than in healthy ones 
(Figure 1), but it becomes close to normal after exercise (Figure 2). This may be explained by 
the partial restoring function of the autonomic nervous system (ANS), especially of the 
parasympathetic system because a more efficient stimulation in concern of a reduction in 
heart rate becomes present. 
Specific time exercise program is, yet, not precise in order to restore ANS due to total 
reinnervation, but current data indicates that combined therapy (drug stimulation of 
reinnervating sympathetic neurons and exercise) can establish better ANS function after 
orthotopic heart transplantation (Burke, 1995). 
Published studies on heart transplant recipients’ rehabilitation have shown better 
hemodynamic function (Braith, 1998b) with dif\ferent training programs. It is clear that 
physical activity immediately following heart transplantation and adherence to an  
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Fig. 10. HR representation after a 12-week exercise program in a healthy subject (in red) and 
in a heart transplantation recipient (in blue).  
individualized program that promotes an active life style helps to restore cardiovascular 
function (Goodman, 2007). Programs include aerobic exercise, weightlifting, flexibility 
exercise, or training in both land and water. 
Each of the programs has a particularity. Their specifications and attention are concerned to 
type of exercise, intensity, volume and frequency of the sections. Knowing these differences 
may help one to better prescribe a training exercise program (Table 2.) 
8. Aerobic exercise 
Aerobic exercise such as walking, running and cycle ergometer can be prescribed on a 
continuous or interval kind, depending on experience or protocol used by rehabilitation 
service. Nonetheless, the intensity of aerobic exercise should be determined according to the 
workload, if possible at the respiratory compensation point reached during the 
cardiopulmonary exercise test in combination to exercise at a pace between “relatively easy 
and slightly tiring”, between 11 and 13 on the Borg Scale (Guimarães, 2008). Exercise 
sessions should be held three times a week with a 5-minute warm up, 30 minutes of aerobic 
training followed by 5 minutes of recovery and 20 minutes of strength exercises. 
9. Weightlifting 
Exercise with weights, adjacent to the aerobic exercises, have been recommended after heart 
transplantation, although hemodynamic function is restored to near normal values, this 
group of patients still shows a significant decrease in muscle mass and strength, bone 
rarefaction and histochemical changes in muscle fiber type from type I to type II (Braith, 
1998; Lindenfeld, 2004a, Lindenfeld, 2004b). 
These persistent changes in the transplant can be minimized with regular practice of 
resistance training with weights and moderate intensity that must be performed in small 
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Specification Aerobic 
Weightlifting 
Flexibility Water 
Static Dynamic
Type 
Interval and 
continuous 
training 
Main muscle 
groups 
8 to 10 (main 
muscle 
groups) 
Main muscle 
groups 
Walking (in 
hot water at 
30 or 31⁰C) 
Intensityƃ 
60% to 70% peak 
VO2 
HR between AT 
and RCP 
30 to 75%MVC
40% to 80% 
1MR 
light to 
moderate 
60% to 70% 
peak VO2 
HR between 
AT and RCP 
VolumeƄ 30 to 40 min 1 to 10 x 6 s 
1 x 4 to 6 
(avoiding 
fatigue) 
3 a 5 
repetitions 
30 a 40 min 
Frequency 5 x a week 
2 x a week-1 (5 
– 10 x a day)§
2 x a week 
(maximal) 
5 x a week 2 x a week 
Progression 
Respect the Borg 
scale perception 
between 13 and 
15 
Tolerable ROM 
(initial); 
Perform 
contraction 
under different 
ROM 
whenever pain 
and 
inflammation 
get lower. Add 
load when 
strength is 
increased 
5-10%-load (a 
week)· 
In order to 
stretch soft 
tissue and 
either to keep 
or increase 
ROM 
Respect the 
Borg scale 
between 13 
and 15 
Attention 
BP lowering 
during exercise 
sections 
whenever Borg 
scale perception 
is greater than 
previous 
sections. 
Contraction > 
10 s may 
increase BP 
- 
Respect 
morphologic
al limits in 
order not to 
cause 
injuries. 
BP lowering 
during 
exercise 
sections 
whenever 
Borg scale 
perception is 
greater than 
previous 
sections. 
 
Table 2. Practical recommendations for exercise prescription. MVC: maximal voluntary 
contraction; AT: anaerobic threshold; RCP: respiratory compensation point; 1MR: one 
maximal repetition test; ROM: range of motion; BP: blood pressure; ƃ Subjects were 
encouraged to begin under their low threshold and increase intensity up to their highest 
threshold, progressively, as tolerated. Ƅ Static: 1) from a 6-second contraction at first, to an 8 
or 10-second contraction, 2) wait 20-second intermission between contractions; Dynamic: 
one series of 4 or 6 repetitions without any muscle fatigue; §subjects should go from 
exercising twice a day to 5-10 times a day.  
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series, with a maximum of ten repetitions for flexors and extensors groups of the upper and 
lower limbs. This results in reduction of osteoporosis and skeletal muscle myopathies 
(caused by the use of glucocorticoids), and contributes to the gain in muscle strength and 
increase in VO2 peak, at the same time (Lindenfeld, 2004b). 
10. Flexibility exercises 
Stretching exercises should be conducted to promote gains on range of motion, balance, to 
stretch the muscles of the neck, lower back, upper and lower limbs. Exercise with elastic can 
be performed in small series of ten repetitions for each muscle prioritizing posterior trunk 
and involving large joints of hip, knee, elbow and shoulder. 
11. Aquatic exercise 
Physical activity in aquatic environment is little reported after cardiac transplantation. 
However, a case report demonstrated potential benefits of training in heated swimming 
pool at 30-31°C, 1.40 meters of depth, with sessions of 40 minutes of exercise: 5-minute 
warm up, 15 minutes of walking on water, 15-minute workout with weights involving large 
joints and 5 minutes of relaxation. Physical activity in aquatic environment is a well 
established method of rehabilitation for patients with significant functional limitations and 
has proven to be effective in cases of obesity after transplantation. 
12. Implication of drug therapy in exercise 
During the last 25 years there has been a significant increase in survival of patients 
undergoing heart transplantation (Guba, 2002), generally, as a result of advanced 
immunosuppressive therapy to control organ rejection since the transplanted heart 
originates from another organism, and the recipient's immune system attempt to reject it. 
But the most widely used therapy is the combination of several drugs that have different 
modes of action and potential. Some side effects of the use of immunosuppressive 
medication may appear early in the drug treatment and can be minimized with appropriate 
modifications and adjustments of schedules and doses (Chart 1, 2 and 3).  
Since the late onset side effects must be controlled with the inclusion of specific drugs to 
control the clinical signs and symptoms of the patient. The latter is represented by 
corticosteroids, calcineurin inhibitors and TOR inhibitors. 
 Corticosteroids (Prednisone) act as a nonspecific anti-inflammatory, so the rejection process 
suffers a direct influence of the recruitment and activation of T-helper lymphocytes. The 
TOR inhibitors: Tacrolimus (also known as FK-506 or Fujimycin) has a similar action to 
cyclosporine and is used as a second option to cyclosporine, and Sirolimus, also known as 
rapamycin, has an inhibitory effect on activation and proliferation of T cells. So, these 
immunosupressive drugs reduce the infection risk, but may have some undesirable adverse 
effects (Bortolotto, 1997; Fiorelli, 1996), such as nephrotoxic effects, artery damage and 
narrowing, left ventricle hypertrophy, increased likelihood of bone fractures and infections. 
These entire side effects contribute to related health problems over time, so it makes 
professional responsible for their physical rehabilitation more attempted to effects during 
exercise as increased blood pressure, transient ischemic attack (TIA). 
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Moreover, there has been growing clinical consensus that specific training regimens 
(endurance and resistance) in heart transplant recipients can be efficacious adjunctive 
therapies in the prevention of immunosuppression-induced side effects and may be an 
effective countermeasure for corticosteroid-induced osteoporosis and skeletal muscle 
myopathy. 
Heart transplanted recipients who participate in specific resistance training programs 
successfully restore bone mineral density (BMD) in both the axial and appendicular skeleton 
to pretransplantation levels, increase lean mass to levels greater than pretransplantation, 
and reduce body fat. In contrast, those who do not participate in resistance training lose 
approximately 15% BMD from the lumbar spine early in the postoperative period and 
experience further gradual reductions in BMD and muscle mass late after transplantation. 
(Braith, 2000) 
 
Medicine Side Effects Exercise limitations 
Corticosteroids 
(Prednisone) 
Hypertention  Left ventricle hypertrophy, damage to the arteries, 
brain, heart, kidney and even sudden death. 
Hyperglycemia Damage to the arteries, brain, heart, and kidney. 
Hyperlipidemia  Damage to the arteries, brain, heart, and kidney. 
Diabetes  Damage to the arteries, brain, heart, and kidney, 
peripheral neuropathy, loss of balance and falls. 
Weight gain  Gallstones and Diabetes. 
Osteoporosis Bone fracture 
Cushingoid 
appearance 
NA 
Mood changes Not adherence to an exercise protocol 
Cataract  Incoordination and loss of balance 
Calcineurin 
inhibitors 
(Cyclosporine) 
Kidney 
vasoconstriction  
Nephrotoxicity and sodium retention (which 
contribute to body plasma volume) 
Hyperkalemia  Cardiopulmonary arrest 
Hypertension  Left ventricle hypertrophy, damage to the arteries, 
brain, heart, kidney and even death. 
Venous 
thrombosis 
Pulmonary thromboembolism  
Migraine  Not adherence to an exercise protocol 
Tremor  Incoordination  
Paresthesia  Loss of balance and falls 
Gout  Pain and ROM limitation 
Gum hyperplasia NA 
Hepatotoxicity  NA 
Chart 1. Side effects and mainly corticosteroids and calcineurin inhibitor interferences. NA: 
not applicable. ROM: range of motion. 
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Medicine Side Effects Exercise limitations 
Tacrolimus Kidney 
vasoconstriction  
Nephrotoxicity (similar to cyclosporine) 
Hypertension*  Left ventricle hypertrophy, damage to the arteries, 
brain, heart, kidney and even sudden death. 
Hyperlipidemia*  Damage to the arteries, brain, heart, and kidney. 
Diabetes # Damage to the arteries, brain, heart, and kidney, 
peripheral neuropathy, loss of balance and falls. 
Sirolimus Bone marrow aplasia Thrombocytopenia, anemia and leukopenia 
Hyperlipidemia  Damage to the arteries, brain, heart, and kidney. 
Peripheral edema Difficulty on progressing ROM, loss of balance and falls. 
Wound healing 
impairment. 
Incapacity of moving the affected area, not adherence 
to an exercise protocol. 
Chart 2. Side effects and mainly TOR inhibitors interferences. * fewer than cyclosporine’s 
side-effect; # greater than cyclosporine’s side-effect; 
Medicine Side Effects Exercise limitations 
Azathioprine Neutropenia and 
thrombocytopenia 
Increased risk of infections, venous 
thrombosis, pulmonary thromboembolism 
anemia, and bleeding. 
 Nausea, vomit Not adherence to an exercise protocol 
 Pancreatitis, 
hepatotoxicity and cancer. 
NA 
Mycophenolate Neutropenia Increased risk of infections 
 Nausea, vomit Not adherence to an exercise protocol 
Chart 3. Side effects and mainly antiproliferative agents interferences.  
13. Final comments 
Heart transplantation is indicated as therapy for patients in the end stage of heart failure. 
These patients, despite the fact they trade their damaged hearts for functional ones, they 
remain with several impairments, as muscle weakness, and develop some other disabilities 
because of the transplantation procedure itself and due to the use of required drugs to 
control rejection. 
Regular physical activity in general has shown potential benefits for the control and 
reduction of chronic degenerative diseases, which should be incorporated as a therapeutic 
agent after cardiac transplantation. However, studies on cardiac rehabilitation in 
transplanted patients are isolated and inconclusive regarding the answer in the long term 
effect on the immune system, neurohormonal, musculoskeletal and adherence to the 
program. Furthermore, these studies refer only to cardiovascular training, leaving aside 
structural and postural changes, such as rotations, shoulder girdle and pelvic 
misalignments-scapular of the patient, which can be found in the majority who have some 
functional deviation as stiffed vertebral joints and shorten muscle. Another important aspect 
that we consider is the socio-cultural reference of transplant patients, which can often limit 
or even refuse to participate on a physical training program.  
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The effect of physical conditioning after transplantation is mainly attributed to higher 
peripheral efficiency, but there has also been found a degree of cardiac adaptation.  
In current practice of heart transplant recipients’ therapy, further studies are needed to 
elucidate the role of physical activity on the interaction of physiological and clinical 
responses in this group of patients.  
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